TrialTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.

Petra Leidinger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.